Proteases and Lipoprotein Receptors in Alzheimer's Disease

Authors: Alexandra Makarova; Suzanne E. Williams; Dudley K. Strickland

Source: Cell Biochemistry and Biophysics, Volume 41, Number 1, August 2004 , pp. 139-178(40)

Publisher: Humana Press

Buy & download fulltext article:

OR

Price: $42.00 plus tax (Refund Policy)

Abstract:

Alzheimer's disease (AD) is the leading cause of senile dementia, and is a complex disorder. The pathological hallmarks of AD were discovered by Dr. Alois Alzheimer in 1907, and include deposits of amyloid or senile plaques and neurofibrillar tangles. Plaques are composed of a peptide, termed the Abeta peptide, that is derived by proteolytic processing of the amyloid precursor protein (APP), while neurofibrillar tangles result from a hyperphosphorylation of the tau protein. Mechanisms associated with the formation of plaques and neurofibrillar tangles and their respective contributions to the disease process have been intensely investigated. Proteolytic processing of APP that results in the generation of the Abeta peptide is now well understood and is influenced by several proteins. Recent evidence suggests that the Abeta levels are carefully regulated, and several proteases play an important role in removing the Abeta peptide. Finally, it is becoming apparent that several members of the LDL receptor family play important roles in the brain, and may modulate the course of AD.

Keywords: LRP; Alzheimer's disease; VLDL receptor; ApoER2; protease; amyloid precursor protein; apoE

Document Type: Miscellaneous

Publication date: 2004-08-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page